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Abstract
Hematopoietic stem cells in mammals are known to reside mostly in the bone marrow, but also
transitively passage in small numbers in the blood. Experimental findings have suggested that
they exist in a dynamic equilibrium, continuously migrating between these two compartments.
Here we construct an individual-based mathematical model of this process, which is parametrised
using existing empirical findings from mice. This approach allows us to quantify the amount of
migration between the bone marrow niches and the peripheral blood. We use this model to
investigate clonal hematopoiesis, which is a significant risk factor for hematologic cancers. We
also analyse the engraftment of donor stem cells into non-conditioned and conditioned hosts,
quantifying the impact of different treatment scenarios. The simplicity of the model permits a
thorough mathematical analysis, providing deeper insights into the dynamics of both the model
and of the real-world system. We predict the time taken for mutant clones to expand within a
host, as well as chimerism levels that can be expected following transplantation therapy, and the
probability that a preconditioned host is reconstituted by donor cells.
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Author Summary
Clonal hematopoiesis – where mature myeloid cells in the blood deriving from a single stem cell
are over-represented – is a major risk factor for overt hematologic malignancies. To quantify how
likely this phenomena is, we combine existing observations with a novel stochastic model and
extensive mathematical analysis. This approach allows us to observe the hidden dynamics of the
hematopoietic system. We conclude that for a clone to be detectable within the lifetime of a
mouse, it requires a selective advantage. I.e. the clonal expansion cannot be explained by neutral
drift alone. Furthermore, we use our model to describe the dynamics of hematopoiesis after stem
cell transplantation. In agreement with earlier findings, we observe that niche-space saturation
decreases engraftment efficiency. We further discuss the implications of our findings for human
hematopoiesis where the quantity and role of stem cells is frequently debated.
Introduction
The hematopoietic system has evolved to satisfy the immune, respiratory, and coagulation
demands of the host. A complex division tree provides both amplification of cell numbers and a
variety of differentiated cells with distinct roles in the body [1–3]. In a typical adult human
∼ 1011 terminally differentiated blood cells are produced each day [3–5]. It has been argued that
the division tree prevents the accumulation of mutations, which are inevitable given the huge
number of cell divisions [6–8]. At the base of the tree are hematopoietic stem cells (HSCs).
These have the ability to differentiate into all hematopoietic cell lineages, as well as the capacity
to self-renew [1,9], although the exact role of HSCs in blood production is still debated [10,11].
With an aging population, hematopoietic malignancies are increasingly prevalent [12]. Clonal
hematopoiesis – where a lineage derived from a single HSC is overrepresented – has been
identified as a significant risk factor for hematologic cancers [13–15]. To assess the risks posed to
the host we need an understanding of how fast clones are growing, when they initiate, and if they
would subvert physiologic homeostatic control.
The number of HSCs within a mouse is estimated at ∼0.01% of bone marrow
cellularity [16,17], which amounts to ∼10, 000 HSCs per host [3, 16,18,19]. In humans this
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number is subject to debate; limited data has lead to the hypothesis that HSC numbers are
conserved across all mammals [18], but the fraction of ‘active’ HSCs depends on the mass of the
organism [20] (see also Refs [5, 21] for a discussion).
Within an organism, the HSCs predominantly reside in so-called bone marrow niches:
specialised micro-environments that provide optimal conditions for maintenance and regulation
of the HSCs [22, 23]. There are likely a finite number of niches within the bone marrow, and it is
believed that they are not all occupied at the same time [16]. The number of niches is likely
roughly equal to the number of HSCs, and through transplantation experiments in mice it has
been shown that ∼1% of the niches are unoccupied at any time [16,24]. A similar number of
HSCs are found in the peripheral blood of the host [16]. These free HSCs are phenotypically and
functionally comparable to (although distinguishable from) bone marrow HSCs [19,25]. The
HSCs have a residence time of minutes in the peripheral blood, and parabiosis experiments
(anatomical joining of two individuals) have shown that circulating HSCs can engraft to the bone
marrow [25]. It has also been shown that HSCs can detach from the niches without cell division
taking place [19]. These findings paint a picture of HSCs migrating between the peripheral blood
and the bone marrow niches, maintaining a dynamic equilibrium between the two compartments.
In this manuscript we construct a model from the above described processes, and we use this
to answer questions about clonally dominant hematopoiesis. We first consider this in mice, where
we use previously reported values to parametrise our model. The model is general enough that it
also captures scenarios of transplantation into both preconditioned (host HSCs removed) and
non-preconditioned hosts: the free niches and the migration between compartments also allows
for intravenously injected donor HSCs to attach to the bone marrow niches and to contribute to
hematopoiesis in the host. In the discussion we comment on the implications of these results for
human hematopoiesis.
Materials and Methods
Our model, shown schematically in Fig 1, contains two compartments for the HSCs. The bone
marrow (BM) compartment consists in our model of a fixed number, N , of niches. This means
that a maximum of N HSCs can be found there at any time, but generally the number of
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occupied niches is less than N . The peripheral blood (PB) compartment, however, has no size
restriction. The number of cells in the PB and BM at a given time are given by s and n,
respectively.
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Fig 1. Compartmental model for a single population of HSCs. The bone marrow (BM)
compartment has a fixed total of N niches. At a given time, n of the niches are occupied, and
N − n remain unoccupied. The peripheral blood (PB) compartment has no size restriction, and
at a given time contains s HSCs. A HSC in the BM can detach at rate d and enter the PB, while
a cell in the PB can attach to an unoccupied niche with rate a(N − n)/N . Here (N − n)/N is
the fraction of unoccupied niches. HSCs may die in the PB or BM with rates δ and δ′.
Reproduction (symmetric division) of HSCs occurs at rate β. The new daughter cell attaches to
an empty niche with probability ρ, otherwise it is ejected into the PB. Dynamics are concretely
described by the reactions in Eq (1).
The dynamics are indicated by arrows in Fig 1. Our model is stochastic and individual based,
such that events are chosen randomly and waiting times between events are exponentially
distributed. Simulations are performed using the Gillespie stochastic simulation algorithm
(SSA) [26]. HSCs in our model are only capable of dividing when attached to a niche; outside the
niche, pre-malignant cells are incapable of proliferating due to the unfavourable conditions. Upon
division, the new daughter HSC enters another niche with probability ρ, or is ejected into the PB.
Here ρ depends on the number of free niches, i.e. ρ = ρ(n), and should satisfy ρ(N) = 0, such
that a daughter cell cannot attach if all niches are occupied. Likewise, the migration of a HSC
from the PB to the BM should depend on the number of empty niches. We choose the
attachment rate as a(N − n)/N per cell. In general, cells can die in both compartments.
However, we expect the death rate in the PB, δ, to be higher than the death rate in the BM, δ′,
as the PB is a less favourable environment.
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Table 1. Parameter values from empirical murine observations. These are
equilibrium values in healthy mice.
Description Parameter Value Reference
Total niches N 10,000 niches [16,19]
Occupied niches n∗ 9,900 niches [16,24]
PB HSCs s∗ 1–100 cells [19, 25]
Average HSC division rate β 1/39 per day [34]
Time in PB ` 1–5 minutes [25]
For our initial analysis, we assume there is no death in the BM compartment (δ′ = 0), and
new cells are always ejected into the PB (ρ = 0). These assumptions are relaxed in our detailed
analysis, which can be found in the Supporting Information (SI).
A two-compartment model has been considered previously by Roeder and colleagues [27,28].
The rate of migration between the compartments is controlled by the number of cells in each
compartment, as well as a cell-intrinsic continuous parameter which increases or decreases
depending on which compartment the cell is in. This parameter also controls the differentiation
of the HSCs. Further models of HSC dynamics, for example [29–33], have not considered the
migration of cells between compartments. For example, Dingli et al. consider a constant-size
population of HSCs in a homogeneous microenvironment [31, 32]. Competition between wildtype
and malignant cells then follows a Moran process. In our model the BM compartment size is
fixed, but cell numbers can fluctuate.
To initially parametrise our model we consider only one species of HSCs: those which belong
to the host. In a steady-state organism, the number of HSCs in the PB and BM are close to their
equilibrium values, which are labelled as s∗ and n∗, respectively. These values have been
reported previously in the literature for mice, and are provided in Table 1. Other previously
reported values include the total number of HSC niches N , HSC division rate β, and the time
that cells spend in the PB, which we denote as `. Using these values we can quantify the
remaining model parameters δ, d, and a. These results are discussed in the next section.
When considering a second population of cells, such as a mutant clone or donor cells following
transplantation, we may want to impose a selective effect relative to the host HSCs. We therefore
allow the mutant/donor cells to proliferate with rate β2 = (1 + ε)β, where ε represents the
strength of selection. For ε = 0, the mutant/donor cells proliferate at the same rate as the host
HSCs. In the SI we consider the general scenario of selection acting on all parameters. Our
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analysis delivers an interesting result: the impact of selection on clonal expansion is independent
of which parameter it acts on (provided δ′ = ρ = 0).
For clonality and chimerism we use the same definition: the fraction of cells within the BM
compartment that are derived from the initial mutant or the donor population of cells. Typically,
experimental measurements of clonality and chimerism use mature cells rather than HSCs.
However, this is beyond the scope of our model so we use HSC fraction as a proxy for this
measurement. We are therefore implicitly assuming that HSC chimerism correlates with mature
cell chimerism. The literature on the role of HSCs in native hematopoiesis is split [10, 35] (also
reviewed in [36]). For the division rate of HSCs in mice we use the value β = 1/39 per day. This
is the average division rate of all HSCs within a host deduced from CFSE-staining
experiments [34], but again there is some disagreement in reported values for this
quantity [34,37,38]. These differences arise from the interpretation of HSC cell-cycle dynamics.
More concretely, our model consists of four sub-populations: n1 is the number of host or
wildtype cells located in the BM, and s1 is the number of cells of this type in the PB. Likewise,
n2 and s2 are the number of mutant/donor cells in the BM and PB, respectively. The cell
numbers are affected by the processes indicated in Fig 1 (with δ′ = ρ = 0). The effect of these
events and the rate at which they happen are given by the following reactions:
Reproduction: (ni, si)
βini−−−−−−−−−−−−→ (ni, si + 1), (1a)
Death: (ni, si)
δisi−−−−−−−−−−−−→ (ni, si − 1), (1b)
Detachment: (ni, si)
dini−−−−−−−−−−−−→ (ni − 1, si + 1), (1c)
Attachment: (ni, si)
aisi(N − n)/N−−−−−−−−−−−−→ (ni + 1, si − 1), (1d)
where n =
∑
i ni, and (N − n)/N is the fraction of unoccupied niches. The corresponding
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deterministic dynamics are described by the ODEs:
dn1
dt
= −d1n1 + a1s1N − n
N
, (2a)
dn2
dt
= −d2n2 + a2s2N − n
N
, (2b)
ds1
dt
= (d1 + β1)n1 −
(
δ1 + a1
N − n
N
)
s1, (2c)
ds2
dt
= (d2 + β2)n2 −
(
δ2 + a2
N − n
N
)
s2. (2d)
Recall we have β1 = β and β2 = (1 + ε)β in the main manuscript, along with δ1 = δ2 = δ,
a1 = a2 = a, and d1 = d2 = d.
Accessibility
A Wolfram Mathematica notebook containing the analytical details can be found at
https://github.com/ashcroftp/clonal-hematopoiesis-2017. This location also contains
the Gillespie stochastic simulation code used to generate all data in this manuscript, along with
the data files.
Results
Steady-state HSC dynamics in mice
By considering just the cells of the host organism, we can compute the steady state of our system
from Eq (2), and hence express the model parameters δ, d, and a in terms of the known
quantities displayed in Table 1. These expressions are shown in Table 2, where we also
enumerate the possible values of these deduced model parameters. Even for the narrow range of
values reported in the literature (Table 1), we find disparate dynamics in our model. At one
extreme, the average time a cell spends in the BM compartment (1/d) can be less than two hours
(for s∗ = 100 cells and ` = 1 minute). Thus under these parameters the HSCs migrate
back-and-forth very frequently between the niches and blood, and the flux of cells between these
compartments over a day (s∗/`) is significantly larger than the population size. In fact, under
these conditions 144, 000 HSCs per day leave the marrow and enter the blood. With slower
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Table 2. Deduced model parameter values. The parameters δ, d, and a are given here as
values per day. The remaining parameters (N , β, n∗) are given in Table 1.
Value (per day)
Description Parameter Expression s∗: 1 cell 10 cells 100 cells
`: 1 min 5 mins 1 min 5 mins 1 min 5 mins
Death rate δ βn
∗
s∗ 250 250 25 25 2.5 2.5
Detachment rate d s
∗
`n∗ − β 0.12 0.0034 1.4 0.27 15 2.9
Attachment rate a
(
1
` − βn
∗
s∗
)
N
N−n∗ 120,000 3,400 140,000 26,000 140,000 29,000
turnover in the PB compartment (` = 5 minutes, but still s∗ = 100), the average BM residency
time of a single HSC is eight hours, and 28, 800 HSCs leave the bone marrow per day. At the
other extreme, if the PB compartment is as small as reported in Ref. [19] (s∗ = 1 cell), then the
residency time of each HSC in the bone marrow niche is between 8 and 290 days (for ` = 1 and 5
minutes, respectively). Under these conditions the number of cells entering the PB compartment
per day is 1, 440 and 288, respectively. For an intermediate PB size of s∗ = 10, the BM residency
time is between 17 and 90 hours (for ` = 1 and 5 minutes, respectively), and the flux of cells
leaving the BM is a factor ten greater than for s∗ = 1.
Clonal dominance in mice
Clonal dominance occurs when a single HSC generates a mature lineage which outweighs the
lineages of other HSCs, or where one clone of HSCs outnumbers the others. The definition of
when a clone is dominant is not entirely conclusive. Previous studies of human malignancies have
used a variant allele frequency of 2%, corresponding to a clone that represents 4% of the
population [39,40]. For completeness we investigate clonality ranges from 0.1% to 100%.
In the context of disease, this clone usually carries specific mutations which may confer a
selective advantage over the wildtype cells in a defined cellular compartment. The de novo
emergence of such a mutant occurs following a reproduction event. Therefore, in our model with
ρ = 0, after the mutant cell is generated it is located in the PB compartment, and for the clone
to expand it must first migrate back to the BM. This initial phase of the dynamics is considered
in general in the next section of transplant dynamics, where a positive number S of
mutant/donor cells are placed in the PB. We find (as shown in the SI) that the expected number
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of these cells that attach to the BM after this initial dynamical phase is
n2 =
a(N − n∗)/N
δ + a(N − n∗)/N S =
(
1− β`n
∗
s∗
)
S. (3)
We then apply a fast-variable elimination technique to calculate how long it takes for this clone
to expand within the host [41, 42]. This procedure reduces the dimensionality of our system, and
makes it analytically tractable. A full description of the analysis can be found in the SI, but we
outline the main steps and results of this procedure below.
We first move from the master equation – the exact probabilistic description of the stochastic
dynamics – to a set of four stochastic differential equations (SDEs) for each of the variables via
an expansion in powers of the large parameter N [43]. We then use the projection method of
Constable et al. [41, 42] to reduce this system to a single SDE describing the relative size of the
clone. This projection relies on the weak-selection assumption, i.e. 0 ≤ ε 1. The standard
results of Brownian motion are then applied to obtain the statistics of the clone’s expansion. In
particular, the probability that the mutant/donor HSCs reach a fraction 0 < σ ≤ 1 of the
occupied BM niches is given by
φ(z0, σ) =
1− e−Λz0
1− e−Λσξ , (4)
where z0 is the initial clone size can be found explicitly from Eq (3), such that z0 = n2/N . We
also have ξ = n∗/N , and Λ is a constant describing the strength of deterministic drift relative to
stochastic diffusion. Concretely, we have
Λ = εN
dβ + dδ + βδ
(d+ β)δ
= εN
(
1 +
s∗
n∗
− β`
)
. (5)
The mean time for the clone to expand to size σ (i.e. the mean conditional time) is written as
Tξ(z0, σ) = θ(z0, σ)/φ(z0, σ), where θ(z0, σ) is given by the solution of
∂2θ(z0, σ)
∂z20
+ Λ
∂θ(z0, σ)
∂z0
= −NB
φ(z0, σ)
z0(ξ − z0) , θ(0) = θ(σξ) = 0. (6)
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Here B is another constant describing the magnitude of the diffusion, and is given by
B = d(d+ β)βδ
2
ξ(dβ + dδ + βδ)2
=
βN
s∗
s∗
n∗ − β`(
1 + s
∗
n∗ − β`
)2 . (7)
Although a general closed-form solution to Eq (6) is possible, it is too long to display here.
Instead we use an algebraic software package to solve the second-order differential equation. A
similar expression to Eq (6) can be obtained for the second moment of the fixation time, as
shown in [44] and repeated in the SI.
The first scenario we consider is the expansion of a neutral clone (ε = 0); i.e. how likely is it
that a single cell expands into a detectable clone in the absence of selection? It is known that the
time to fixation of a neutral clone in a fixed-size population grows linearly in the system size [45].
Interestingly and importantly, in intestinal crypts this fixation is seen frequently because
N = O(10) [46]. In the hematopoietic system, however, it likely takes considerably longer than
this due to the relatively large number of stem cells. Solving Eq (6) with ε = 0 gives the mean
conditional expansion time as
Tξ(z0, σ) =
N
B
[
ξ − z0
z0
log
(
ξ
ξ − z0
)
+
1− σ
σ
log(1− σ)
]
. (8)
From this solution we find that it takes, on average, 5–45 years for a neutral clone to reach 1%
clonality (∼ 100 HSCs). Expanding to larger sizes takes considerably longer, as highlighted in
Fig 2. Therefore, clonal hematopoiesis in mice is unlikely to result from neutral clonal expansion;
for a clone to expand within the lifetime of a mouse it must have a selective advantage. Neutral
results for human systems are considered in the discussion.
When the mutant clone has an advantage, there is always some selective force promoting this
cell type. Therefore the probability of such a clone expanding is higher than the neutral case, as
seen from Eq (4). In Fig 2 we illustrate the time taken for a single mutant HSC to reach
specified levels of clonal dominance for different selective advantages. Advantageous clones
(β2/β > 1) initially grow exponentially in time [Fig 2(a)], and are much faster than neutral
expansion (β2/β = 1). These clones can reach levels of up to 90% relatively quickly, however
replacing the final few host cells takes much longer. The advantage that a mutant clone must
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Fig 2. Time taken for a clone initiated from a single HSC to expand under different levels of
selection. (a) Time taken for a mutant clone to expand as a function of the level of clonality
reached, with colour indicating the selective effect of the mutant. (b) Time taken for a mutant
clone to expand as a function of the selective effect, with colour indicating different levels of
clonality. Symbols are results from 103 simulations of the full model (with associated standard
deviations), and solid lines are predictions from Eq (6). Shaded regions are the predicted
standard deviations, using the formula presented in the SI. Here ` = 3 minutes, s∗ = 100, and
the remaining parameters are as in Table 1.
have if it is to represent a certain fraction of the population in a given period of time can be
found from Fig 2(b). For a single mutant to completely take over in two years, it requires a fold
reproductive advantage of β2/β ≈ 2 [dashed lines in Fig 2(b)]. This means that the cells in this
clone are dividing at least twice as fast as the wildtype host cells. To achieve 1% clonality in this
timeframe, the advantage only has to be β2/β ≈ 1.2. For the clone to expand in shorter time
intervals, a substantially larger selective advantage is required. For example, 100% clonality in
six months from emergence of the mutant requires β2/β ≈ 5.5, i.e. the dominant clone needs to
divide more than five times faster than the wildtype counterparts.
As shown in the SI, Eq (4) and Eq (6) are equivalent to the results obtained from a
two-species Moran process. This suggests the two-compartment structure is not necessary to
capture the behaviour of clonal dominance. However, the consideration of multiple compartments
is required to understand transplantation dynamics, as covered in the next section.
Transplant success in mice
We now turn our attention to the scenario of HSC transplantation. As previously mentioned this
situation is analogous to the disease spread case, with the exception that the initial ‘dose’ of
HSCs can be larger than one. We first consider the case of a non-preconditioned host. We then
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move onto transplantation in preconditioned hosts, where all host cells have been removed.
Engraftment in a non-preconditioned host
Multiple experiments have tested the hypothesis that donor HSCs can engraft into a host which
has not been pretreated to remove some or all of the host organism’s HSCs [16,19,34,47–53].
These studies have found that engraftment can be successful; following repeated transplantations
mice display a chimerism with up to 40% of the HSCs deriving from the donor [48–50].
In this scenario we start with a healthy host organism and inject a dose of S donor HSCs into
the PB compartment, in line with the experimental protocols mentioned above. These donor
cells can be neutral, or may have a selective (dis)advantage. Injecting neutral cells reflects the in
vivo experiments described above, while advantageous cells can be used to improve the chances of
eliminating the host cells. Transplanting disadvantageous cells would reflect the introduction of
‘normal’ HSCs into an already diseased host carrying advantageous cells. We do not consider this
scenario further here, as the diseased cells are highly unlikely to be replaced without host
preconditioning.
We can separate the engraftment dynamics of these donor cells into two different regimes: i)
the initial relaxation to a steady state where the total number of HSCs is stable, and ii)
long-time dynamics eventually leading to the extinction of either the host or donor HSCs. We
focus on these regimes separately. Upon the initial injection of the donor HSCs, the PB
compartment contains more cells than the equilibrium value s∗. This leads to a net flux of cells
attaching to the unoccupied niches in the BM until the population relaxes to its equilibrium size.
Once the equilibrium is reached, the initial dynamics end, and the long-term noise-driven
dynamics take over (discussed below). The challenge for this first part is to determine how many
of the donor HSCs have attached to the BM at the end of the initial dynamics.
We identify two distinct behaviours which occur under low and high doses of donor HSCs. If
the dose is small (S  N − n∗), then the number of donor HSCs that attach to the BM is given
by Eq (3), and is proportional to the dose size S. To obtain this result we have assumed that the
number of occupied niches remains constant, such that each donor cell has the same chance of
finding an empty niche. However, if the dose of donor HSCs is large enough then all niches
become occupied and the BM compartment is saturated; attachment to the BM can only occur
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following a detachment. Using this assumption, the initial dynamics can then be described by
the linear ODEs
dn2
dt
= −dn2 + dN
s(t)
s2, (9a)
ds2
dt
= (β + d)n2 −
(
δ +
dN
s(t)
)
s2, (9b)
where s(t), the total number of cells in the PB compartment, is found from s˙ = βN − δs. A
derivation of Eq (9) can be found in the SI.
The predicted chimerism, and the accuracy of these predictions, at the end of the initial
phase are shown in Fig 3. The efficiency of donor cell engraftment decreases in the large-dose
regime (S > N − n∗). This is simply because the niche-space is saturated, so HSCs spend longer
in the blood and are more likely to perish. If the lifetime in the PB (`) is short, then we have
more frequent migration between compartments, as highlighted in Table 2. Hence smaller ` leads
to higher chimerism. The approximation from Eq (9) becomes increasingly accurate for larger
doses. The two approximations break down at the cross-over region between small and large
doses. In this regime the number of occupied niches does not reach a stable value.
If the donor cells have a selective (dis)advantage, then the deterministic dynamics predict the
eventual extinction of either the host or donor cells. However, the selective effect is usually small
and only acts on a longer timescale. Therefore the initial dynamics are largely unaffected by
selection, and we assume neutral donor cell properties when we model the initial dynamics.
The inefficiency of large doses can be overcome by administering multiple small doses over a
long period. In this way we prevent the niches from becoming saturated and fewer donor cells die
in the PB. Hence we should be able to obtain a higher level of engraftment when compared to a
single-bolus injection of the same total number of donor HSCs. These effects have been tested
experimentally [19,48–50]. Parabiosis experiments are also an extreme example of this; they
represent a continuous supply of donor cells [25]. As shown in Fig 4, our model captures the
same qualitative behaviour as reported in the experiments: Multiple doses lead to higher levels of
chimerism at the end of the initial phase of dynamics. This effect is highlighted more when the
total dose size is large. Using our analysis we know how efficient each dose is, and what levels of
chimerism can be achieved. Hence our model can be used to optimise dosing schedules such that
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Fig 3. Initial chimerism of neutral donor cells in a healthy, non-preconditioned host. Upper
panels depict the level of donor chimerism shortly after a dose of neutral donor cells, S, is
injected into the host. Symbols are from numerical integration of Eq (2). The small-dose regime
is described by Eq (3) (solid lines for S < 103), and the large-dose regime is described by Eq (9)
(solid lines for S > 102). Lower panels show the accuracy of these approximations when
compared to the numerical integration of Eq (2). This error takes the form
(approx.−exact)/exact. (a) s∗ = 10, and (b) s∗ = 100. The lifetime in the PB, `, is measured in
minutes. Remaining parameters are as in Table 1.
they are maximally efficient.
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Fig 4. Number of donor HSCs attaching to the BM of a non-preconditioned host after a single
dose (dashed lines) or seven daily doses (solid lines). Both treatments use the same total number,
S, of donor HSCs. Trajectories are from numerical integration of the ODEs Eq (2). Here we have
` = 3 minutes, s∗ = 100, and the remaining parameters are as in Table 1.
We note here that engraftment efficiency is only important when donor cells are rare and
there is no danger to life. This is the case, for example, in experimental protocols when tracking
small numbers of cells. It makes sense to here use the multiple dosing strategy. Transplantation
following preconditioning, however, provides a more viable approach to disease treatment where
patient survival needs to be maximised. In this case the dose size should be increased, but it
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should be considered that there are diminishing returns in engraftment when the dose size is
large enough to saturate all open niches. This dose size can be read from Fig 3.
The long-term dynamics are handled in the same way as the clonal dominance results above;
we use Eq (4) and Eq (6) to show how the number of donor cells injected into the PB affects the
probability that they expand (as opposed to die out), and the time it takes for the host cells to
be completely displaced. One key result is that a dose of just eight HSCs with an advantage of
β2/β = 1.1 has over 50% chance to fixate in the host. However, the time for this to happen is
∼ 16 years. With a reproductive advantage of β2/β = 1.5 the success rate is ∼ 95% for the same
dose, and the time taken now falls to ∼ 4 years. Further results are found in the SI.
Engraftment in a preconditioned host
HSC transplantation procedures are often preceded by treatment or irradiation of the host –
referred to as host preconditioning. This greatly reduces the number of host HSCs in the BM
compartment. For this section we assume complete conditioning such that no host HSCs remain,
i.e. myeloablative conditioning. Following the pre-treatment, a dose of donor HSCs of size S is
injected into the PB compartment. We then want to know the probability that these cells
reconstitute the organism’s hematopoietic system. For this section we assume that donor HSCs
have identical properties to the wildtype cells (i.e. no selection). We further assume that all
donor HSCs have the potential to reconstitute the hematopoietic system in the long-term – in
experiments this is not always the case as not all cells which are sorted as phenotypic HSCs (as
defined by surface markers) are functional, reconstituting HSCs (see e.g. [54]). Because of this
assumption, we only show results for the injection of a single donor HSC into the conditioned
host (S = 1). Higher doses lead to a greater probability of reconstitution. A further assumption
is, that the host maintains (or is provided with) enough mature blood cells during the
reconstitution period to sustain life.
We consider two approaches for estimating the probability of hematopoietic reconstitution.
As a first-order approximation, the probability that a single HSC in the PB compartment dies is
ψ = δ/(δ + a). Here we have assumed that all niches are unoccupied, such that the attachment
rate per cell is a(N − 0)/N = a. For a dose of size S, the reconstitution probability is
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ϕ = 1− ψS . Hence we have
ϕ = 1−
(
δ
δ + a
)S
. (10)
This prediction, Eq (10), is shown as dotted lines in Fig 5, which, however, does not agree with
results from the model. The second approach considers all possible combinations of detachments
and reattachments, as well as reproduction events. This leads to a reconstitution probability,
given a dose of S donor cells, of
ϕ = 1−
(
δ
δ + a
d+ β
β
)S
, (11)
which is derived in the SI. This result, Eq (11), is shown as solid lines in Fig 5, and is in excellent
agreement with the reconstitution probability observed in simulations. From these results we can
conclude that, in our model, HSCs migrate multiple times between the PB and BM before they
establish a sustainable population. It is also the case that in this model a single donor HSC is
sufficient to repopulate a conditioned host in ∼ 90 – 99% of cases across all the parameter ranges
reported in Table 1.
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Fig 5. Probability of reconstitution from a single donor HSC which is injected into a
preconditioned host. Symbols are results from 105 simulations of the stochastic model. For
efficiency we ran the simulations until the population reached either 0 (extinction) or 100
(reconstitution), and we assume no further extinction events occur once this upper limit has been
reached. Dotted lines are the ‘first-order’ prediction of Eq (10). Solid lines are the predictions of
Eq (11) which account for detachments, reattachments, and reproduction events. Remaining
parameters are as in Table 1.
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Discussion
We have introduced a mathematical model that describes the back-and-forth migration of
hematopoietic stem cells between the blood and bone marrow within a host. This is motivated
by the literature of HSC dynamics in mice. The complexity of the model has been kept to a
minimum to allow us to parametrise it based on empirical results. The model is also analytically
tractable, permitting a more thorough understanding of the dynamics and outcomes. For
example, on long timescales we find the that the two-compartment model is equivalent to the
well-studied Moran model. Meanwhile, analysis of the reconstitution of a preconditioned mouse
shows that in our model HSCs migrate multiple times between the BM and PB compartments
before establishing a sustainable population.
Given these dynamics we first investigate clonal dominance, where a clone originating from a
single mutant cell expands in the HSC population. In mice we find that a selective advantage is
required if the clone is to be detected within a lifetime: A clone starting from a single cell with a
reproduction rate 50% higher than the wildtype can expand to 1% clonality in one year. A cell
dividing twice as fast as the wildtype reaches > 10% clonality in the same timeframe. Such
division rates can be reached by MPN-initiating HSCs [55]. The requirement of a selective
advantage agrees with the clinical literature where, for example, mutants are known to enjoy a
growth advantage under inflammatory conditions [56,57].
The model also captures the scenario of stem cell transplantation. Engraftment into a
non-preconditioned host is analogous to clonal dominance, except that the clone is initiated by
multiple donor cells. For small doses of donor HSCs, the number of cells that attach to the BM is
directly proportional to the size of the dose. For larger doses the BM niches are saturated, leading
to lower engraftment efficiency. Donor chimerism can be improved by injecting the host with
multiple small doses, as opposed to a large single-bolus dose of the same size. This agrees with
results that have been reported in the empirical literature [19, 48–50]. Following preconditioning
of a mouse to remove all host cells, we find that a single donor HSC is sufficient to repopulate a
host in ∼90–99% of cases. This result rests on the assumption that the donor stem cell was, in
fact, a long-term reconstituting HSC, which may not be the case in experimental setups.
In the SI we consider the effects of death occurring in the BM niche (δ′ 6= 0), and the direct
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attachment of a new daughter cell to the bone marrow niche (ρ 6= 0). We find that death in the
niche increases the migration rate of cells between the PB and BM compartments, which can
greatly reduce the attachment success of the low-frequency mutant/donor cells. However, the
direct attachment of daughter cells to the niche has no effect on the initial attachment of
donor/mutant cells, and on the level of chimerism achieved in the initial phase of the dynamics.
Broadening the scope of our investigation, clonality of the hematopoietic system is a major
concern for human health [13–15,39]. Clinical studies have shown that 10% of people over 65
years of age display clonality, yet 42% of those developing hematologic cancer displayed clonality
prior to diagnosis [13]. Our model, and the subsequent analysis, can be applied to this scenario.
However, the number of HSCs in man is debated, with estimates of ∼400 [20,58], O(104) [18], or
O(107) [5]. Estimates as high as O(109) can also be obtained by combining the total number of
nucleated bone marrow cells [59] with stem cell fraction measurements [1, 60,61]. In Fig 6 we
summarise how neutral and advantageous clones starting from a single HSC expand in human
hematopoietic systems. We find that 4% clonality [39,40] can be achieved in a short period of
time for even neutral clones [Fig 6(a)]. If the human HSC pool is O(103) or smaller, we would
expect clonal hematopoiesis and the associated malignancies to be highly abundant in the
population, perhaps more-so than they currently are [13–15,39]. On the other hand, for a system
size of N = 106 it takes thousands of years for a single neutral HSC to expand to detectable
levels, making neutral expansion extremely unlikely to result in clonal hematopoiesis. Therefore,
for clonal hematopoiesis to occur in a pool of this size or larger [5] the mutants would require a
significant fitness advantage over the wildtype HSCs. We also consider a range of parameters,
and even relax the α = % = 0 condition, in Fig S1 and Fig S2. We find no significant differences
in the predictions of our model.
Limitations
Our model has been kept to a minimal level of biological detail to allow for parametrisation from
experimental results. This has the added benefit of analytic tractability. The model is
constructed under steady-state conditions, which is the case for neutral clonal expansion.
However, in the case of donor-cell transplantation following myeloablative preconditioning, we
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Fig 6. Time taken until a clone initiated from a single cell represents 4% [39,40] of the human
HSC pool, as a function of the total number of niches in the system. Colours represent the
selective advantage of the invading clone. Lines are given by the solution of Eq (6), and shaded
regions represent the calculated standard deviation (details in the SI). Remaining parameters are
β = 1/40 week−1 [62], ` = 60 minutes, s∗ = 0.01N , and n∗ = 0.99N . Here `, s∗, and n∗ are
extrapolated from the murine data, where `human ≈ 10`mouse, which follows the same scaling as
the HSC division rate, β. Further parameter combinations are shown in Fig S1 and Fig S2.
References refer only to the source of parameters; no part of this figure has been reproduced
from previous works.
are no longer in a steady state. Here we expect some regulatory mechanisms to affect the HSC
dynamics, including a faster reproductive rate and a reduced probability of cells detaching from
the niche. There are also possibilities for mutants to exploit or evade the homeostatic
mechanisms [63]. Different mechanisms of stem cell control have recenty been considered for
hematopoietic cells [64], as well as in colonic crypts [65].
The steady state assumption is also unable to capture the different dynamics associated with
ageing. For example, in young individuals the hematopoietic system is undergoing expansion. In
our model there is no distinction between young and old systems. In Fig S3 we demonstrate the
impact of a (logistically) growing number of niches. Such growth means clonal hematopoiesis is
likely to be detected earlier, and therefore would increase our lower bound estimate on the
number of HSCs in man. Telomere-length distributions have been used to infer the HSC
dynamics from adolescence to adulthood, and have suggested a slowing down of HSC divisions as
life progresses [66]. Faster dynamics in early life would lead to a higher incidence among young
people, which again increases our lower bound estimate.
It is also not entirely clear how to extrapolate the parameters from the reported mouse data
to a human system. Here we have taken the simplest approach and appropriately scaled the
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unknown parameters. However, hematopietic behaviour may differ between species. For example,
results of HSC transplantation following myeloablative therapy in non-human primates have
shown that clones of hematopoietic cells persist for many years [67,68]. This could be due to
single HSCs remaining attached to the niche and over-contributing to the hematopoietic system,
or due to clonal expansion of the HSCs to large enough numbers such that a contributing
fraction will always be found in the BM. Both of these mechanisms are features of our model:
the time a cell spends in the BM is much longer than the time in the PB and can be increased
further by tuning the model parameters, namely by decreasing s∗ or increasing `. Changes to
these parameters seems to have little effect on our predictions of clonal expansion, as shown in
Fig S1 and Fig S2. Clonal extinctions are also a feature of our work, and have been identified in
non-human primates [68].
A more general point to discuss is the role of hematopoietic stem cells in blood production. In
our model we are only considering HSC dynamics, however it has been proposed that downstream
progenitor cells are responsible for maintaining hematopoiesis [11] in mice. Hence, myeloid
clonality would also be determined by the behaviour of these progenitor cells. On the other hand,
an independent study found that HSCs are driving multi-lineage hematopoiesis [10], suggesting
we are correct in our approach. Again we also expect there to be variation between species in
this balance of HSC/progenitor activity. With little quantitative information available, we have
assumed that HSCs are the driving force of steady-state hematopoiesis across mice and humans.
Conclusion
In conclusion, this simple mathematical model encompasses multiple HSC-engraftment scenarios
and qualitatively captures empirically observed effects. The mathematical calculations provide
insight into how the dynamics of the model unfold. The analytical results, which we have verified
against stochastic simulations, allow us to easily investigate how parameter variation affects the
outcome. We now hope to extend this analysis, incorporating further effects of disease and
combining this model with the differentiation tree of hematopoietic cells.
Supporting Information
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SI Supporting mathematical details. Contains detailed derivations of all equations
presented in the manuscript, including the details of the projection method. The analysis is
carried out for unrestricted parameters, including selective effects on all parameters and
permitting death in the BM space, as well as direct attachment of new daughter cells to the niche.
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Fig S1 Clonality in man: more parameter combinations and death within niches.
Time taken until a clone initiated from a single cell represents 4% [39,40] of the human HSC
pool, as a function of the total number of niches in the system. Colours represent the selective
advantage of the invading clone. Solid lines correspond to death only within the niches (α = 0),
while dashed lines represent equal death rates in both compartments (α = 1; see SI for details).
Lines are generated using mathematical formulae in the SI. Remaining parameters are β = 1/40
week−1 [62], n∗ = 0.99N , and % = 0. Some predictions are missing when d ≤ 0 and/or a ≤ 0;
these parameter regimes are incompatible with our model.
Fig S2 Clonality in man: more parameter combinations and reproduction into
BM. Time taken until a clone initiated from a single cell represents 4% [39,40] of the human
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HSC pool, as a function of the total number of niches in the system. Colours represent the
selective advantage of the invading clone. Solid lines correspond to the daughter cell entering the
PB compartment after reproduction (% = 0), while dashed lines represent daughter cells
remaining in the BM (% = 1; see SI for details). Lines are generated using mathematical formulae
in the SI. Remaining parameters are β = 1/40 week−1 [62], n∗ = 0.99N , and α = 0. Some
predictions are missing when d ≤ 0 and/or a ≤ 0; these parameter regimes are incompatible with
our model.
Fig S3 Predicted and simulated incidence curves of clonal hematopoiesis in man:
constant size and under growth. The cumulative probability density function (CDF) of
times to reach 4% clonality [39, 40] when starting from a single neutral mutant in a normal host.
Shaded regions are incidence curves from simulations using either a constant niche count of
N = 104, or a logistically growing number of niches with N˙ ≈ rN(1−N/K), where K = 104,
r = 0.3 per year, and N(0) = K/20. These parameters represent a maturation period of ∼ 20
years to reach N ≈ K. Lines are predicted incidence curves which assume normally-distributed
times to clonality, using the mean and variance formulae as described in the SI, and constant
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population size as indicated in the legend (minimum and maximum number of niches).
Remaining parameters are β = 1/40 week−1 [62], n∗ = 0.99N , s∗ = 0.01N , and ` = 60 minutes.
Finally, we only consider here the conditional incidence time, which have been normalised by the
fixation probability. This probability is 20 times larger for the neutral mutant in the growing
model when compared to the fixed number of niches.
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Supporting Information (SI)
SI.I Model description
The full model, as depicted in Fig 1 of the main manuscript, consists of four sub-populations and
six processes for each cell type (wildtype and mutant/donor). The number of host or wildtype
cells located in the bone marrow (BM) is n1, while s1 is the number of cells of this type in the
peripheral blood (PB). Likewise, n2 and s2 are the number of mutant/donor cells in the BM and
PB, respectively. The BM has a maximum capacity of N cells, representing the finite niche space
in an organism. The cell numbers are affected by birth, death, detachment from the BM, and
attachment to the BM. The effect of these events and the rate at which they happen are given by
the following reactions:
Reproduction into PB: (ni, si)
[1− ρi(n)]βini−−−−−−−−−−−−→ (ni, si + 1), (SI.1a)
Reproduction into BM: (ni, si)
ρi(n)βini−−−−−−−−−−−−→ (ni + 1, si), (SI.1b)
Death in PB: (ni, si)
δisi−−−−−−−−−−−−→ (ni, si − 1), (SI.1c)
Death in BM: (ni, si)
δ′ini−−−−−−−−−−−−→ (ni − 1, si), (SI.1d)
Detachment: (ni, si)
dini−−−−−−−−−−−−→ (ni − 1, si + 1), (SI.1e)
Attachment: (ni, si)
aisi(N − n)/N−−−−−−−−−−−−→ (ni + 1, si − 1), (SI.1f)
where n =
∑
i ni, and (N − n)/N is the fraction of unoccupied niches. The function ρi(n)
represents the probability for the new daughter cell following a reproduction event to attach
directly to the BM, rather than entering the PB. This function should satisfy 0 ≤ ρi(n) ≤ 1, as
well as ρi(N) = 0. For simplicity we choose a binary function such that
ρi(n) =
%i if n < N,0 otherwise. (SI.2)
We express the death rate in the BM, δ′i, in terms of the original death rate δi, such that
δ′i = αδi. With this parametrisation, setting α = 0 prevents death from occurring within the BM,
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and α = 1 makes HSC death independent of the environment. As the BM is a more favourable
environment for the HSCs, we expect 0 ≤ α ≤ 1. As α is effectively a property of the
environment, we assume it is identical for both host and mutant/donor cells. We note here that
there are no direct interaction terms between host cells and mutant/donor cells (no switching
from type 1 to type 2 etc.). We use the following parametrisation for the reaction parameters:
β1 = β, β2 = (1 + εγβ)β, (SI.3a)
δ1 = δ, δ2 = (1 + εγδ)δ, (SI.3b)
δ′1 = αδ1 δ
′
2 = αδ2, (SI.3c)
d1 = d, d2 = (1 + εγd)d, (SI.3d)
a1 = a, a2 = (1 + εγa)a, (SI.3e)
%1 = % %2 = (1 + εγ%)%. (SI.3f)
Here ε represents the strength of selection. For analysis purposes discussed below, we assume
0 ≤ ε 1. For ε = 0, we have the so-called neutral model. The parameters γj (j ∈ {β, δ, d, a, %})
satisfy γj = O(1). They allow the parameters to be varied independently. In the main
manuscript we restrict these parameters to γβ = 1 and γδ = γd = γa = γ% = 0, along with
α = % = 0, but we carry out the analysis in general here.
Considering a steady-state system in the absence of the mutant/donor cells (n2 = s2 = 0), the
deterministic dynamics of the system are described by ordinary differential equations (ODEs):
dn1
dt
= (%β − d− αδ)n1 + as1N − n1
N
, (SI.4a)
ds1
dt
= [d+ (1− %)β]n1 −
(
δ + a
N − n1
N
)
s1. (SI.4b)
From these ODEs we can obtain expressions for the equilibrium size of the BM and PB
compartments, n∗ and s∗, respectively. These are given by
n∗ = N
(
1− δ(d+ αδ − %β)
a(β − αδ)
)
, (SI.5a)
s∗ =
(β − αδ)
δ
n∗. (SI.5b)
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Table SI.1. Deduced parameter value ranges (units are per day). Here we have fixed ` = 3
minutes and % = 0.
Value (per day)
Parameter Expression s∗: 1 cell 100 cells
α: 0 10−4 10−2 1 0 10−4 10−2 1
δ βn
∗
s∗+αn∗ 250 130 2.5 0.026 —– 2.5 —– 1.3 0.025
d s
∗
`n∗ − β ———— 0.022 ———— ———— 4.8 ————
a
(
1
` − βn
∗
s∗+αn∗
)
N
N−n∗ 23,000 35,000 — 48,000 — ——— 48,000 ———
From Eq (SI.5b), the death rate δ can be expressed in terms of β, s∗, n∗, and the variable
parameter α. Furthermore, a cell in the PB compartment (in equilibrium) can either die with
rate δ or attach to an unoccupied niche with rate a(N − n∗)/N . Hence the expected lifetime of a
cell in the PB is ` = [δ + a(N − n∗)/N ]−1. From this we can obtain and expression for the
attachment rate a. Finally, d is found from Eq (SI.4a). Thus for the non-valued parameters δ, d,
and a, we have
δ =
βn∗
s∗ + αn∗
, (SI.6a)
d =
s∗
`n∗
− (1− %)β, (SI.6b)
a =
(
1
`
− βn
∗
s∗ + αn∗
)
N
N − n∗ (SI.6c)
These expressions, and the possible range of values, are given in Table 2 of the main manuscript
for α = % = 0. A further example is provided in Table SI.1 of this document for α 6= 0. By
introducing death in the niche, we affect the balance of cells leaving and entering each
compartment. The total number of cells produced (βn∗) must be matched by the total number
of cells that die. As we have increased the number of cells that are susceptible to death, we must
decrease the death rate δ. Hence, δ is a decreasing function of α. To replace the cells that die
within the BM, we need to increase the flux of cells from the PB to the BM. In other words,
death in the BM must be compensated by an increased rate of migration between the PB and
BM compartments. Hence, we have that a is an increasing function of α. The detachment rate d
is independent of α, but is an increasing function of % to ensure enough cells migrate to the PB.
For completeness, the deterministic dynamics of the two-species system are described by the
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ODEs:
dn1
dt
= (%β − d− αδ)n1 + as1N − n
N
, (SI.7a)
dn2
dt
= (%2β2 − d2 − αδ2)n2 + a2s2N − n
N
, (SI.7b)
ds1
dt
= [d+ (1− %)β]n1 −
(
δ + a
N − n
N
)
s1, (SI.7c)
ds2
dt
= [d2 + (1− %2)β2]n2 −
(
δ2 + a2
N − n
N
)
s2, (SI.7d)
with n = n1 + n2.
SI.II Initial dynamics and chimerism
In the scenario of donor cell transplantation, the PB compartment initially contains more cells
than the equilibrium value in the neutral model (s1 + s2 > s
∗). This leads to a net flux of cells
attaching to the BM, and hence n1 + n2 > n
∗. The continuing attachment–detachment dynamics
allows the donor cells to replace the host cells in the BM. Meanwhile, surplus cells in the PB are
dying off and the population relaxes to its equilibrium size (n1 + n2 = n
∗ and s1 + s2 = s∗). The
host cells in the BM are effectively displaced by the new donor HSCs. Once the equilibrium is
reached the initial dynamics end. We find that the effect of selection, ε, only acts on a long
timescale, and has little influence on the outcome of initial dynamics. Therefore we treat the
donor cells as neutral until the long-term noise-driven dynamics (discussed below) take over.
For small doses of donor HSCs, and especially the case of S = 1 when a de novo mutant is
generated, the number of additional cells in the BM (n1 + n2 − n∗) is small. We can neglect this
expansion of the BM pool and approximate the number of occupied niches as a constant, n∗. By
considering only first-order reactions of the donor HSCs (i.e. the injected cells either die or
attach to the BM, there is no reproduction or detachment), we can predict the number of donor
HSCs that attach to the BM. We find
n2 =
a(N − n∗)/N
δ + a(N − n∗)/N S =
(
1− `βn
∗
s∗ + αn∗
)
S. (SI.8)
Hence for small doses the chimerism achieved is directly proportional to the dose size. The
34/46
simplified process that led to Eq (SI.8) (only first-order dynamics) predicts s2 = 0 after the
initial dynamics, which is incorrect. However, we know the relation between si and ni in
equilibrium [Eq (SI.5b)], which tells us that s2 = (β − αδ)n2/δ.
If the dose of donor HSCs is large enough, all niches become occupied and the BM
compartment is saturated. In this case a niche that has been vacated (either by detachment or
death) is immediately filled, either by a cell from the PB or from a reproduction event. For
example, if an n1 cell detaches from the BM or dies within the BM, then it can be immediately
replaced by an s2 cell from the PB, or by an n2 cell following reproduction with attachment.
Here we consider these combined detachment–attachment dynamics. As the vacant niche is
immediately occupied, we approximate the rate of the coupled detachment–attachment reaction
as a single exponential step determined by the rate at which the niche becomes available (either
d or αδ).
For s1 – the number of wildtype cells in the PB – we have an increase due to reproduction
with rate βn1 (niches are saturated so the new daughter cell enters the PB with certainty), and a
decrease due to death at rate δs1. Furthermore, s1 will increase if an s2 attaches to the BM
following the detachment of an n1 cell; this process occurs at rate dn1s2/s, where s = s1 + s2 and
s2/s is the probability that an s2 cell attaches rather than s1. Also, s1 can decrease if it attaches
to a niche vacated by n2 cell. Finally, an s1 cell can attach to a niche that opens due to the death
of the occupant, which happens with rate αδNs1/s (here we assume n1 + n2 = N). Similar
dynamics follow for s2. Hence, for the PB cells we have the following simplified equations
ds1
dt
= βn1 − δs1 + d
(
n1
s2
s
− n2 s1
s
)
− αδN s1
s(t)
, (SI.9a)
ds2
dt
= βn2 − δs2 + d
(
n2
s1
s
− n1 s2
s
)
− αδN s2
s(t)
. (SI.9b)
The size of the PB pool follows the linear equation and solution
ds
dt
= (β − αδ)N − δs
⇒ s(t) =
(
s(0)− (β − αδ)N
δ
)
e−δt +
(β − αδ)N
δ
. (SI.10)
Here we assume the N − n∗ unoccupied niches are immediately filled after injection, such that
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s(0) = s∗ + S − (N − n∗) and n(t ≥ 0) = N .
For the cells in the BM, we construct the coupled dynamics in a similar way; a niche is
cleared at rate (d+ αδ)N , and the cell is replaced immediately by one from the PB, or by
reproduction within the niche. Wildtype BM cells can increase following the detachment/death
of an n2 cell with rate (d+αδ)n2[(s1/s) + (n1/N)]. Here s1/s represents the attachment of an s1
cell (as opposed to s2), and n1/N the reproduction within the niche of an n1 cell. The decrease
of n1 follows analogously, and occurs with rate (d+ αδ)n1[(s2/s) + (n2/N)]. Hence, we can now
write down the approximate ODEs for this scenario:
dn1
dt
= (d+ αδ)
(
n2
s1
s
− n1 s2
s
)
, (SI.11a)
dn2
dt
= (d+ αδ)
(
n1
s2
s
− n2 s1
s
)
, (SI.11b)
where the terms due to reproduction have cancelled out. Although not obvious from above,
Eq (SI.9) and Eq (SI.11) are actually linear in the ni and si. Writing n1 = N − n2 and
s1 = s− s2 we have
dn2
dt
= −(d+ αδ)n2 + (d+ αδ)N
s
s2, (SI.12a)
ds2
dt
= (β + d)n2 −
(
δ +
(d+ αδ)N
s
)
s2, (SI.12b)
along with n2(0) = N − n∗ and s2(0) = S − (N − n∗). Using these equations we can predict the
value of n2 once the PB has returned to its equilibrium size.
SI.III Clonal dominance
SI.III.1 General approach and the neutral scenario
Once the mutant/donor cells have established themselves within the BM compartment, we want
to know if and how quickly this clone expands. To this end we use the projection method of
Constable et al. [41, 42]. This analysis is more intuitive when the mutant/donor cells have no
selective advantage, so we first discuss the neutral scenario. In this case once the BM and PB
compartments return to their equilibrium size (n1 + n2 = n
∗ and s1 + s2 = s∗) there is no
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deterministic dynamics; as the mutant/donor cells are neutral when compared to the host, we
have effectively returned to a healthy and stable host. However, the stochastic dynamics of the
individual-based model continue. Cells are continually migrating between the BM and PB
compartments, and reproduction and death events go on. If cell numbers increase [decrease] then
the flux of cells leaving the system increases [decreases] until the equilibrium is restored.
Therefore the deterministic dynamics constrains cell numbers to n1 + n2 = n
∗ and s1 + s2 = s∗.
Cell number fluctuations, however, change the balance between host and mutant/donor cells over
time, and we observe diffusion along the equilibrium line. Eventually, this diffusion leads to the
extinction of either the host or the mutant/donor population of HSCs.
We first move from the master equation – the exact probabilistic description of the stochastic
dynamics – to a set of stochastic differential equations (SDEs) [43]. To this end we introduce the
variables x = (s1, s2, n1, n2)
T/N and expand the master equation in powers of 1/N , using the
fact that N is a large parameter. The evolution of x is determined by the set of SDEs
dxi
dt
= Ai(x) +
1√
N
ηi(t), (SI.13)
where the Ai are the drift terms representing the deterministic dynamics, and the ηi are Gaussian
noise terms which describe the diffusion. The ηi have zero expectation value and correlator
〈ηi(t)ηj(t′)〉 = δ(t− t′)Bij(x). (SI.14)
Here 〈·〉 represents the expectation value over many realisations of the noise. The exact forms of
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the drift vector A and diffusion matrix B (valid for n < N) are
A(x) =

[d+ (1− %)β]x3 − (δ + ay)x1
[d+ (1− %)β]x4 − (δ + ay)x2
(%β − d− αδ)x3 + ayx1
(%β − d− αδ)x4 + ayx2

, (SI.15a)
B(x) =

[d+ (1− %)β]x3 + (δ + ay)x1 0 −dx3 − ayx1 0
0 [d+ (1− %)β]x4 + (δ + ay)x2 0 −dx4 − ayx2
−dx3 − ayx1 0 (%β + d+ αδ)x3 + ayx1 0
0 −dx4 − ayx2 0 (%β + d+ αδ)x4 + ayx2

,
(SI.15b)
where we have used the shorthand y = 1− x3 − x4, which is the fraction of unoccupied niches.
Eq (SI.13) is an approximate description of the full stochastic dynamics. If we neglect the noise
term, we recover the ODEs Eq (SI.7).
The set of points at which the drift vector A is zero is known in dynamical systems theory as
the slow manifold. Our slow manifold, x∗, satisfies the conditions x∗1 + x
∗
2 = s
∗/N and
x∗3 + x
∗
4 = n
∗/N , as well as x∗1 = [(β − αδ)/δ]x∗3 and x∗2 = [(β − αδ)/δ]x∗4. The first two
conditions describe the equilibrium size of the PB and BM compartments, and the latter
conditions describe the balance between reproduction and cell death. These four conditions can
be satisfied parametrically by
x∗(z) =
(
β − αδ
δ
(ξ − z), β − αδ
δ
z, ξ − z, z
)T
, (SI.16)
where ξ = n∗/N and z ∈ [0, ξ]. Hence, our slow manifold is a line through the 4-dimensional
state-space. In other words, if we were to measure the number of donor cells in the BM then we
could infer the number of host cells from the system-size constraint. These numbers, along with
knowledge of the reproduction and death rates, can be used to infer cell numbers in the PB.
Therefore we only need to keep track of one variable, z, to describe our system.
As there is no deterministic drift along our slow manifold (in the neutral scenario), the
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time-evolution of the parametric coordinate z satisfies
dz
dt
=
1√
N
η(t), (SI.17)
where η(t) is Gaussian noise with zero expectation value and correlator
〈η(t)η(t′)〉 = δ(t− t′)B˜11(z). (SI.18)
The expansion (or contraction) of the mutant/donor clone is completely specified by this noise
correlator B˜11, but it is not yet determined. To find it we must project the approximate
dynamics [Eq (SI.13)] onto our slow manifold x∗ [41, 42]. In this way we capture the effects of
the cell number fluctuations described above. To achieve this we note that the Jacobian matrix
of the drift vector along the slow manifold, A(x∗), has a zero eigenvalue. This corresponds to the
direction in which there is no deterministic motion, and hence the associated eigenvector is
directed along the slow manifold. Thus we use the eigenvectors of A(x∗) as a basis, onto which
we decompose the SDEs Eq (SI.13). Selecting only the component along the slow manifold, we
find the correlator
B˜11(z) = 2B z(ξ − z), (SI.19)
where the constant B is given by
B = β[d+ (1− %)β][d+ αδ(1− %)]δ
2
ξ{βδ + βd+ dδ + αδ[β − (d+ αδ)]− %β[β + δ − αδ]}2
=
βn∗N(s∗ + αn∗)[s∗ + αn∗ − n∗`(1− %)β]
[(n∗ + s∗)(s∗ + αn∗)− n∗s∗`β]2 . (SI.20)
The first line of this equation expresses the diffusion constant in terms of the reaction
parameters, while the second line uses Eq (SI.6) to express B in terms of the
experimentally-observed parameters, as well as α and %.
By rescaling time and the coordinate z in Eq (SI.19), it can be shown that the dynamics
along the slow manifold are equivalent to those of the Moran model [41,42].
We can use the standard results of Brownian motion to determine the probability that the
mutant/donor clone expands to a given fraction σ, and the mean time for this to happen [43].
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For example, σ = 0.5 corresponds to a clone that represents 50% of all HSCs. We assume the
dynamics starts at a point x∗(z0) along the slow manifold. Here z0 = n2/N , where n2 is the
number of mutant/donor cells that make up the BM compartment at the end of the initial
dynamics as described in the previous section. In particular, for the case of disease spread
(S = 1), z0 can be found explicitly from Eq (SI.8). The probability that the mutant/donor HSCs
reach a fraction σ ≤ 1 is given by
φ(z0, σ) =
z0
σξ
. (SI.21)
The mean time for this expansion (i.e. the mean conditional time) is given by
Tξ(z0, σ) =
N
B
[
ξ − z0
z0
log
(
ξ
ξ − z0
)
+
1− σ
σ
log(1− σ)
]
. (SI.22)
For σ = 1, we recover the fixation probability and mean conditional fixation time of the
mutant/donor cells.
SI.III.2 With selection
We now repeat this analysis for the non-neutral case, i.e. the mutant/donor cells have a selective
(dis)advantage. For ε > 0, the drift vector in Eq (SI.13) becomes
A(ε)(x) =

[d+ (1− %)β]x3 − (δ + ay)x1
[d+ (1− %)β]x4 − (δ + ay)x2
(%β − d− αδ)x3 + ayx1
(%β − d− αδ)x4 + ayx2

+ε

0
[dγd + (1− %)βγβ − %βγ%]x4 − (δγδ + aγay)x2
0
[%β(γ% + γβ)− dγd − αδγδ]x4 + aγayx2

+O(ε2).
(SI.23)
We assume there is no change in the noise correlator as terms O(ε/N) are negligible; hence we
have B(ε)(x) ≈ B(0)(x) = B(x), as given in Eq (SI.15b).
As there is always some deterministic drift due to the effect of selection, by definition there is
no slow manifold. However, the number of cells leaving the system will still be balanced by
production as described above. This balance point describes a subspace around which the cell
numbers fluctuate. With ε > 0 there will be a tendency for the advantageous cells to replace
their counterparts. This induces a slow drift along the subspace. By integrating the
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Fig SI.1. Time course of ODEs Eq (SI.7) (solid lines) with an initial dose of S = 5, 000 donor
cells into a steady-state host. Selection strengths in this figure are ε ∈ {0, 0.1, 0.5, 1.5}
(increasing in direction of arrow). Dashed lines are the approximate slow subspaces, x˜, recovered
from the projection method. For ε = 0 the ODE time course stops once it reaches the slow
manifold. Increasing ε moves the slow subspace away from the ε = 0 slow manifold. Here we
have selection acting only on the reproduction rate (γβ = 1, γa = γδ = γd = 0), and we have
` = 3 minutes. In the left panel s∗ = 10 and in the right panel s∗ = 100. We here set α = % = 0.
Remaining parameters are as in Table 1 of the main manuscript.
ODEs Eq (SI.7) for a long time we can visualise this subspace. Examples are shown in Fig SI.1
for different selection strengths. In the absence of selection (ε = 0), the trajectory from the
ODEs Eq (SI.7) stops once the slow manifold has been reached. This is the reason why the
dashed line is not accompanied by a solid trajectory for ε = 0. For ε > 0, the advantageous
mutant/donor cells are able to maintain a higher equilibrium population size than the host.
Hence the slow subspaces always lie above the neutral slow manifold.
We can use the projection method to calculate the approximate form of the slow subspace,
x˜(z) [41,42]. This takes the form x˜(z) = x∗(z) + εf(z), and again we only need one variable to
describe our system. These approximations are shown as dashed lines in Fig SI.1, and they
remain highly accurate (compared to numerical integration of the ODEs Eq (SI.7)) even for large
values of ε.
Using the same eigenbasis from the neutral model we can project the dynamics onto the slow
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subspace [41,42]. The SDE describing the motion along the slow subspace is
dz
dt
= A˜1(z) +
1√
N
η(t),
〈η(t)〉 = 0,
〈η(t)η(t′)〉 = δ(t− t′)B˜11(z). (SI.24)
The drift along this subspace, A˜1(z), is of the form
A˜1(z) = εA z(ξ − z), (SI.25)
where the constant A is given by
A = δ
ξ
γa(β − αδ)(d+ αδ − %β)− γdd(β − αδ) + γββ[d+ αδ(1− %)]− γδ[αδ(β − αδ)− β(%β − d− αδ)] + γ%%β(β − αδ)]
βδ + βd+ dδ + αδ(β − d− αδ)− %β[β + (1− α)δ] .
(SI.26)
By setting α = % = 0, we recover
A = dβδ
ξ(dβ + dδ + βδ)
(γβ + γa − γδ − γd). (SI.27)
This expression gives an important result; it doesn’t matter in which sense the cells are
advantageous. A cell with an increased reproduction rate (γβ = 1; γa = γδ = γd = 0) has the
same advantage as a cell which attaches to the BM more quickly (γa = 1; γβ = γδ = γd = 0). All
that matters is the cumulative advantage, γβ + γa − γδ − γd. For this reason we only consider a
reproductive advantage in the presented results in the main manuscript.
Again using the standard results of Brownian motion [43], we find the probability for the
donor cells to represent a fraction σ of the population to be
φ(z0, σ) =
1− e−Λz0
1− e−Λσξ , with Λ =
εNA
B . (SI.28)
This solution is of the same form as that obtained for a Moran model [41,42]. Although a
closed-form solution is possible for the mean conditional time to reach size σ, it is too long to
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Fig SI.2. Fixation probability (a) and time (b) of donor cells in a non-preconditioned host. On
the horizontal axis we plot the initial dose of donor HSCs, S ∈ {1, 2, 4, 8, . . . , 8192}. Symbols are
results from 103 simulations of the stochastic model (with associated standard deviations). Lines
are predictions from Eq (SI.28) and Eq (SI.29). The shaded region in (b) is the standard
deviation calculated from the second moment, Eq (SI.30). Here we have s∗ = 100 cells, and ` = 3
minutes, along with α = % = 0. Remaining parameters are as in Table 1 of the main manuscript.
display here. Instead we use an algebraic software package to solve the second-order differential
equation
Tξ(z0, σ) =
θ(z0, σ)
φ(z0, σ)
,
∂2θ(z0, σ)
∂z20
+ Λ
∂θ(z0, σ)
∂z0
= −NB
φ(z0, σ)
z0(ξ − z0) , θ(0) = θ(σξ) = 0.
(SI.29)
Example results from Eq (SI.28) and Eq (SI.29) are shown in Fig SI.2.
Furthermore, we can write down a set of equations for the second moment of the conditional
time for the mutant/donor clone to reach size σ [44]. The second moment, 〈T 2ξ (z0, σ)〉, is
dependent on the first moment of the conditional time, and hence we must solve the coupled
equations:
∂2θ1(z0, σ)
∂z20
+ Λ
∂θ1(z0, σ)
∂z0
= −NB
φ(z0, σ)
z0(ξ − z0) , θ1(0) = θ1(σξ) = 0, (SI.30a)
∂2θ2(z0, σ)
∂z20
+ Λ
∂θ2(z0, σ)
∂z0
= −2NB
θ1(z0, σ)
z0(ξ − z0) , θ2(0) = θ2(σξ) = 0, (SI.30b)
〈T 2ξ (z0, σ)〉 =
θ2(z0, σ)
φ(z0, σ)
, (SI.30c)
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where the first equation is for the first moment [identical to Eq (SI.29)], and the second equation
is for the second moment. The predicted deviation calculated from this second moment is shown
in Fig SI.2(b).
Full details of all these calculations are found in the accompanying Mathematica notebook
file, which can be found at https://github.com/ashcroftp/clonal-hematopoiesis-2017.
SI.III.3 Further neutral-model calculations
The expansion of neutral clones deserves some further attention, as this process could provide
valuable insight into human hematopoiesis. Firstly, we look at the case α = % = 0 and ask how
does the mean conditional time to σ-level clonality vary depending on the choice of model
parameters. Using Eq (SI.8), along with S = 1, we have an expression for our initial level of
clonality:
z0 =
1
N
s∗ − n∗β`
s∗
. (SI.31)
From Eq (SI.20), we also have the diffusion constant
B = βN
s∗
s∗
n∗ − β`(
1 + s
∗
n∗ − β`
)2 . (SI.32)
Therefore, our mean time [Eq (SI.22)] satisfies
〈Tξ(z0, σ)〉 = s
∗
β
(
1 + s
∗
n∗ − β`
)2
s∗
n∗ − β`
[(
n∗s∗
s∗ − n∗β` − 1
)
log
(
1
1− s∗−n∗β`n∗s∗
)
+
1− σ
σ
log(1− σ)
]
.
(SI.33)
Now assuming that terms O(N) are much larger than terms O(1), that s∗/n∗  1 (blood
compartment much smaller than bone marrow in equilibrium) and β` 1 (migration dynamics
are faster than reproduction), and that σ  1, we can approximate our mean time as
〈Tξ(z0, σ)〉 ≈ 1
β
σ
2
n∗s∗
s∗ − n∗β` . (SI.34)
Note that we are also constrained to s∗ − n∗β` > 0, which comes from the fact that our
attachment and detachment parameters a and d must be positive. If s∗  n∗β`, then we have
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〈Tξ(z0, σ)〉 ≈ σn∗/(2β), which is independent of ` and s∗. As expected, the reproduction rate β
is the dominant parameter determining the time to clonality.
When considering the case of α 6= 0 and ρ 6= 0, we turn to a graphical representation to
highlight the parameter dependence. These results are shown in supplementary figures S1 and S2.
We find that allowing equal death in both compartments (α = 1) or daughter cells to enter the
niche directly (% = 1) has little to no effect on the time to clonality.
Finally, we can obtain a closed-form solution of the second moment equation [Eq (SI.30)] in
the absence of selection. We find
〈T 2ξ (z0, σ)〉 =
2N
B
[
〈Tξ(z0, σ)〉
(
1− σ
σ
log(1− σ)− 1
)
+
N
B
(
Li2(σ)− Li2
(
z0
ξ
))]
, (SI.35)
where Li2(z) is the second-order polylogarithmic function.
SI.IV Engraftment into a preconditioned host
Even if the BM compartment is empty, in the stochastic model there is a finite probability that
all donor cells die before they engraft. We write ψ = Pr(n+ s = 0, t→∞) for the extinction
probability of a single cell. Therefore, the probability that a single donor HSC will reconstitute
the preconditioned host is ϕ = 1− ψ = Pr(n+ s > 0, t→∞). For doses of size S, the
reconstitution probability is ϕ = 1− ψS . For a first-approximation of this probability, we assume
that the donor cells can only either attach to the BM niches or die. The probability that a single
HSC in the PB compartment dies is ψ = δ/(δ + a). Thus the approximate reconstitution
probability is
ϕ = 1−
(
δ
δ + a
)S
. (SI.36)
Here we have assumed that all niches are unoccupied, such that the attachment rate per cell is
a(N − 0)/N = a.
We can also consider multiple attachments and detachments, which could occur before a cell
establishes a sustainable population or dies. As above, the probability that a single HSC in the
PB compartment dies is δ/(δ + a). Alternatively, the HSC can attach to the niche with
probability a/(δ+a). The probability that the cell then detaches from the niche is d/(d+β+αδ),
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the probability of dying within the niche is αδ/(d+ β + αδ), and the probability of reproducing
is β/(d+ β + αδ). Again we have assumed that the number of occupied niches is negligible.
Under these processes, the probability that a single donor HSC becomes extinct is given by
ψ =
δ
δ + a
+
a
δ + a
f(ψ), (SI.37)
where f(ψ) represents the processes that occur once the cell has entered the BM compartment.
It is given by
f(ψ) =
αδ
d+ β + αδ
+
d
d+ β + αδ
ψ +
β
d+ β + αδ
[
(1− %)ψf(ψ) + %f2(ψ)] . (SI.38)
Here the first term is the death of the cell within the BM compartment. The second term
represents detachment and the cell is back where it started, so this is multiplied by ψ. The third
term represents reproduction: either one offspring is ejected to the PB (hence ψ) and the other
remains in the niche [f(ψ)], or both offspring remain in the BM [f2(ψ)]. Solving Eq (SI.38) for
f(ψ), and then using this to solve Eq (SI.37), we find the extinction probability of a single cell.
For % = 0, this is simply
ψ =
δ
δ + a
d+ β + α(δ + a)
β
, (SI.39)
and hence the reconstitution probability given a dose of S donor HSCs is
ϕ = 1−
(
δ
δ + a
d+ β + α(δ + a)
β
)S
. (SI.40)
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